K.-H. Schlingensiepen

1.4k total citations
40 papers, 1.1k citations indexed

About

K.-H. Schlingensiepen is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, K.-H. Schlingensiepen has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 18 papers in Oncology and 14 papers in Genetics. Recurrent topics in K.-H. Schlingensiepen's work include Glioma Diagnosis and Treatment (13 papers), TGF-β signaling in diseases (11 papers) and Cancer Research and Treatments (8 papers). K.-H. Schlingensiepen is often cited by papers focused on Glioma Diagnosis and Treatment (13 papers), TGF-β signaling in diseases (11 papers) and Cancer Research and Treatments (8 papers). K.-H. Schlingensiepen collaborates with scholars based in Germany, India and United States. K.-H. Schlingensiepen's co-authors include W. Brysch, Piotr Jachimczak, Ulrich Bogdahn, Reimar Schlingensiepen, H. Heinrichs, Peter Hau, S. Schmaus, O. Creutzfeldt, В. Е. Парфенов and Anuspandana Mahapatra and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Journal of neurosurgery.

In The Last Decade

K.-H. Schlingensiepen

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K.-H. Schlingensiepen Germany 14 560 365 201 194 138 40 1.1k
Р. В. Холоденко Russia 17 643 1.1× 219 0.6× 190 0.9× 125 0.6× 51 0.4× 49 1.0k
Maria Lia Palomba United States 25 495 0.9× 963 2.6× 142 0.7× 364 1.9× 156 1.1× 84 2.1k
Anda‐Alexandra Calinescu United States 14 307 0.5× 138 0.4× 64 0.3× 180 0.9× 96 0.7× 20 712
Sovann Kaing United States 13 946 1.7× 450 1.2× 311 1.5× 103 0.5× 24 0.2× 14 2.1k
Gerald F. Reis United States 14 724 1.3× 147 0.4× 474 2.4× 332 1.7× 20 0.1× 28 1.6k
Elizabeth A. Novotny United States 16 669 1.2× 250 0.7× 330 1.6× 69 0.4× 28 0.2× 22 1.4k
Wun Chey Sin Canada 18 1000 1.8× 120 0.3× 490 2.4× 151 0.8× 30 0.2× 25 1.5k
Doğukan Mizrak United States 10 541 1.0× 306 0.8× 195 1.0× 96 0.5× 86 0.6× 18 1.1k
María Ángeles Marqués‐Torrejón Spain 14 848 1.5× 188 0.5× 171 0.9× 292 1.5× 33 0.2× 19 1.4k
Donald J. van Meyel Canada 20 587 1.0× 97 0.3× 382 1.9× 147 0.8× 56 0.4× 29 968

Countries citing papers authored by K.-H. Schlingensiepen

Since Specialization
Citations

This map shows the geographic impact of K.-H. Schlingensiepen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.-H. Schlingensiepen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.-H. Schlingensiepen more than expected).

Fields of papers citing papers by K.-H. Schlingensiepen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.-H. Schlingensiepen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.-H. Schlingensiepen. The network helps show where K.-H. Schlingensiepen may publish in the future.

Co-authorship network of co-authors of K.-H. Schlingensiepen

This figure shows the co-authorship network connecting the top 25 collaborators of K.-H. Schlingensiepen. A scholar is included among the top collaborators of K.-H. Schlingensiepen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.-H. Schlingensiepen. K.-H. Schlingensiepen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bogdahn, Ulrich, Peter Hau, Günther Stockhammer, et al.. (2010). Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study. Neuro-Oncology. 13(1). 132–142. 331 indexed citations
2.
Oettle, Helmut, Andreas Hilbig, T Seufferlein, et al.. (2009). 1259 Trabedersen (AP 12009) in the treatment of pancreatic carcinoma and other malignant tumors: interim results of the Phase I/II study. European Journal of Cancer Supplements. 7(2). 138–138. 1 indexed citations
3.
Bogdahn, Ulrich, Peter Hau, Anuspandana Mahapatra, et al.. (2008). Targeted therapy with AP 12009 in recurrent or refractory glioblastoma patients: Results of a phase Iib study. Journal of Clinical Oncology. 26(15_suppl). 2018–2018. 6 indexed citations
4.
Oettle, Helmut, T Seufferlein, Roland M. Schmid, et al.. (2007). Preliminary results of a phase I/II study in pancreatic carcinoma, malignant melanoma, and colorectal carcinoma with the TGF- β2 inhibitor AP 12009. Journal of Clinical Oncology. 25(18_suppl). 4607–4607. 2 indexed citations
5.
Hau, Peter, Ulrich Bogdahn, Ashok Kumar Mahapatra, et al.. (2007). Results of a phase IIb study in recurrent or refractory glioblastoma patients with the TGF-beta-2 inhibitor AP 12009. Journal of Clinical Oncology. 25(18_suppl). 12521–12521. 6 indexed citations
6.
7.
Schlingensiepen, K.-H., et al.. (2004). The TGF-beta1 antisense oligonucleotide AP 11014 for the treatment of non-small cell lung, colorectal and prostate cancer: Preclinical studies. Journal of Clinical Oncology. 22(14_suppl). 3132–3132. 24 indexed citations
8.
Schlingensiepen, K.-H., et al.. (2004). The TGF-beta1 antisense oligonucleotide AP 11014 for the treatment of non-small cell lung, colorectal and prostate cancer: Preclinical studies. Journal of Clinical Oncology. 22(14_suppl). 3132–3132. 13 indexed citations
9.
Schlingensiepen, K.-H., et al.. (2004). TGF-β2 suppression by the antisense oligonucleotide AP 12009 as treatment for pancreatic cancer: preclinical efficacy data. Journal of Clinical Oncology. 22(14_suppl). 4106–4106. 4 indexed citations
10.
Schlingensiepen, Reimar, W. Brysch, & K.-H. Schlingensiepen. (1997). Antisense : from technology to therapy : lab manual and textbook. 15 indexed citations
11.
Bertram, James P., Martin Killian, W. Brysch, K.-H. Schlingensiepen, & Michael Kneba. (1994). Reduction of erbB2 Gene-Product in Mamma Carcinoma Cell Lines by erbB2 mRNA-Specific and Tyrosine Kinase Consensus Phosphorothioate Antisense Oligonucleotides. Biochemical and Biophysical Research Communications. 200(1). 661–667. 45 indexed citations
12.
Brysch, W., et al.. (1994). Inhibition of p185c-erbB-2 proto-oncogene expression by antisense oligodeoxynucleotides down-regulates p185-associated tyrosine-kinase activity and strongly inhibits mammary tumor-cell proliferation.. PubMed. 1(2). 99–105. 27 indexed citations
13.
14.
Jachimczak, Piotr, Ulrich Bogdahn, J. Schneider, et al.. (1993). The effect of transforming growth factor-β2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma. Journal of neurosurgery. 78(6). 944–951. 113 indexed citations
15.
Grimm, Rita, K.-H. Schlingensiepen, W. Brysch, & Wolfgang Tischmeyer. (1992). DIFFERENTIAL EXPRESSION OF PROTOONCOGENES AND HEAT-SHOCK PROTEINS DURING LEARNING AND MEMORY FORMATION IN RAT-BRAIN. European Journal of Neuroscience. 152–152.
16.
Brysch, W., et al.. (1991). Regional and temporal expression of sodium channel messenger RNAs in the rat brain during development. Experimental Brain Research. 86(3). 562–7. 72 indexed citations
17.
Röther, Susanne, W. Brysch, K.-H. Schlingensiepen, & Roman Schmidt. (1990). Synthesis and ultrastructural distribution of ependymins in goldfish brain analyzed by insitu hybridezation and immonugold labeling. MPG.PuRe (Max Planck Society). 371(11). 1031–1031. 1 indexed citations
18.
Brysch, W., et al.. (1990). The topology of the thalamo-cortical projections in the marmoset monkey (Callithrix jacchus). Experimental Brain Research. 81(1). 1–17. 24 indexed citations
19.
Kneba, Michael, I Bolz, Hermann Herbst, et al.. (1990). Polymerase Chain Reaction Analysis of t(14;18) Junctional Regions in B-Cell Lymphomas. Leukemia & lymphoma. 3(2). 109–117. 8 indexed citations
20.
Brysch, W., et al.. (1984). The second, intralaminar thalamo-cortical projection system. Anatomy and Embryology. 169(2). 111–118. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Р. В. Холоденко Breakdown of academic impact, for papers by Maria Lia Palomba Breakdown of academic impact, for papers by Anda‐Alexandra Calinescu Breakdown of academic impact, for papers by Sovann Kaing Breakdown of academic impact, for papers by Gerald F. Reis Breakdown of academic impact, for papers by Elizabeth A. Novotny Breakdown of academic impact, for papers by Wun Chey Sin Breakdown of academic impact, for papers by Doğukan Mizrak Breakdown of academic impact, for papers by María Ángeles Marqués‐Torrejón Breakdown of academic impact, for papers by Donald J. van Meyel
Rankless by CCL
2026